DK0830143T3 - Anvendelse af leukæmiinhiberende faktor og endothelinantagonister - Google Patents

Anvendelse af leukæmiinhiberende faktor og endothelinantagonister

Info

Publication number
DK0830143T3
DK0830143T3 DK96913814T DK96913814T DK0830143T3 DK 0830143 T3 DK0830143 T3 DK 0830143T3 DK 96913814 T DK96913814 T DK 96913814T DK 96913814 T DK96913814 T DK 96913814T DK 0830143 T3 DK0830143 T3 DK 0830143T3
Authority
DK
Denmark
Prior art keywords
inhibitory factor
leukemia inhibitory
endothelin antagonists
antagonist
endothelin
Prior art date
Application number
DK96913814T
Other languages
Danish (da)
English (en)
Inventor
Jennie P Mather
Nicholas F Paoni
Kathleen King
Elizabeth A Luis
Napoleone Ferrara
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0830143T3 publication Critical patent/DK0830143T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK96913814T 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister DK0830143T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42738395A 1995-04-24 1995-04-24
PCT/US1996/005498 WO1996033740A1 (en) 1995-04-24 1996-04-17 Use of leukemia inhibitory factor and endothelin antagonists

Publications (1)

Publication Number Publication Date
DK0830143T3 true DK0830143T3 (da) 2003-06-16

Family

ID=23694642

Family Applications (2)

Application Number Title Priority Date Filing Date
DK96913814T DK0830143T3 (da) 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister
DK02016730T DK1287832T3 (da) 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK02016730T DK1287832T3 (da) 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor

Country Status (12)

Country Link
EP (2) EP1287832B1 (de)
JP (1) JPH11504332A (de)
AT (2) ATE233570T1 (de)
AU (1) AU702375B2 (de)
CA (1) CA2214636C (de)
DE (2) DE69635630T2 (de)
DK (2) DK0830143T3 (de)
ES (1) ES2254564T3 (de)
IL (1) IL117998A (de)
MX (1) MX9707939A (de)
WO (1) WO1996033740A1 (de)
ZA (1) ZA963274B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000001404A1 (en) 1998-07-06 2000-01-13 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for $i(in vitro) fertilization
EP1549198A4 (de) * 2002-09-30 2007-03-28 Univ Duke Thymusatrophi
JP2011231014A (ja) * 2008-08-27 2011-11-17 Keiichi Fukuda 心不全の治療剤
EP2371860A1 (de) * 2010-04-05 2011-10-05 Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron Den humanen leukaemieinhibierenden Faktor (LIF) erkennender Antikörper und Verwendung von LIF-Antikörpern bei der Behandlung von Krankheiten im Zusammenhang mit ungewollter Zellproliferation
SI3555132T1 (sl) 2016-12-19 2024-04-30 Medimmune Limited Protitelesa proti LIF in njihove uporabe
US10583191B2 (en) 2016-12-19 2020-03-10 Mosaic Biomedicals Slu Antibodies against LIF and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4231393A (en) * 1992-05-08 1993-12-13 Genentech Inc. Antibodies to leukemia inhibitory factor
WO1995008550A1 (en) * 1993-09-24 1995-03-30 Abbott Laboratories Endothelin antagonists

Also Published As

Publication number Publication date
AU702375B2 (en) 1999-02-18
CA2214636C (en) 2009-12-22
EP1287832A3 (de) 2003-04-16
EP0830143B1 (de) 2003-03-05
EP0830143A1 (de) 1998-03-25
DE69626510D1 (de) 2003-04-10
ZA963274B (en) 1997-10-24
WO1996033740A1 (en) 1996-10-31
MX9707939A (es) 1997-12-31
JPH11504332A (ja) 1999-04-20
DE69635630D1 (de) 2006-01-26
ATE233570T1 (de) 2003-03-15
DE69635630T2 (de) 2006-08-10
DK1287832T3 (da) 2006-05-01
EP1287832A2 (de) 2003-03-05
CA2214636A1 (en) 1996-10-31
IL117998A0 (en) 1996-08-04
ES2254564T3 (es) 2006-06-16
IL117998A (en) 2001-04-30
EP1287832B1 (de) 2005-12-21
ATE313333T1 (de) 2006-01-15
DE69626510T2 (de) 2003-12-11
AU5665896A (en) 1996-11-18

Similar Documents

Publication Publication Date Title
DK0574457T3 (da) Antiviral nucleosidkombination
DK1294757T3 (da) Glucagonlignende peptid 1-analoger
FI894095A0 (fi) Vaermare foer anvaendning i mikrovaogsugnar.
FI891716A7 (fi) HIV-proteaasi-inhibiittoreita, jotka ovat käyttökelpoisia AIDS'in hoidossa
DE69206378D1 (de) Patientenliegetische.
NO871091D0 (no) Komposittanordning for katodisk beskyttelse av substrater i kontakt med denne, og anvendelse av anordningen.
DE68920545D1 (de) Polyolefinlaminat mit hoher Festigkeit und hohem Elastizitätsmodul, das verbesserte Festkörper-Tiefziehfähigkeit aufweist.
DE69932510D1 (de) Vaskularisierungsinhibitoren
AU9064991A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
IT8983533A0 (it) Dispositivo per la regolazione del frontale nei cassetti
DK1287832T3 (da) Anvendelse af antagonist af leukæmiinhiberende faktor
ITMI912509A1 (it) Uso della nimesulide nel trattamento della cataratta
DE59004277D1 (de) Copolymerisat sowie dessen Verwendung.
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
ATE154507T1 (de) Dentalwerkstoffe auf basis von (meth)-acrylaten
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
DE68906245D1 (de) Therapeutisches mittel gegen aids.
NO875189D0 (no) Knapporgan med festeanordning.
FI952018A7 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskri ptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
FI924018A0 (fi) 1,4-dihydropyridiner med paf-antagonistisk aktivitet.
ES1022839Y (es) Bragas monouso.
ES1007222Y (es) Punta estimuladora perfeccionada.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
ES1008159Y (es) Mesa de billar perfeccionada.